Prism Data Raises $20M Series A for Cash-Flow Underwriting
Prism Data’s $20M Series A backs cash-flow underwriting. The investment test is production adoption, reliable transaction inputs and measurable lending outcomes.
Prism Data’s $20M Series A backs cash-flow underwriting. The investment test is production adoption, reliable transaction inputs and measurable lending outcomes.
Tolan’s $30M financing backs a persistent AI companion. We examine the investors, undisclosed terms and the retention, trust and compute-cost trade-off.
Town’s $108M Series B backs AI assistants that work across teams. The investment test is permission control, durable team adoption and cost per completed workflow.
Nouscom’s $135M Series D backs a registration-enabling trial of investigational NOUS-209. The funding is confirmed; clinical success remains to be demonstrated.
Tenstorrent’s $1.5B Series E values it at $6.2B post-money. The next test is manufacturing scale, usable software and repeat deployment of Galaxy servers.
Even Healthcare’s reported $50M Series B backs Bengaluru hospital expansion. The key test is whether managed care can scale with sustainable hospital economics.